Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cypress Pharmaceutical, a specialty pharmaceutical company, has announced that the FDA has granted final approval of the company's abbreviated new drug application for levetiracetam oral solution, 100mg/ml.
Subscribe to our email newsletter
Levetiracetam oral solution, 100 mg/ml is the AB-rated bioequivalent generic to UCB Pharma’s Keppra, 100mg/ml.
Cypress’s levetiracetam oral solution, 100mg/ml will be available through all the national drug wholesalers and chain drug stores and will begin shipping immediately.